Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Global Alliance for Chronic Disease researchers' statement on multimorbidity.

Hurst JR, Dickhaus J, Maulik PK, Miranda JJ, Pastakia SD, Soriano JB, Siddharthan T, Vedanthan R; GACD Multi-Morbidity Working Group.

Lancet Glob Health. 2018 Dec;6(12):e1270-e1271. doi: 10.1016/S2214-109X(18)30391-7. No abstract available.

PMID:
30420026
2.

Effectiveness-implementation of COPD case finding and self-management action plans in low- and middle-income countries: global excellence in COPD outcomes (GECo) study protocol.

Siddharthan T, Pollard SL, Quaderi SA, Mirelman AJ, Cárdenas MK, Kirenga B, Rykiel NA, Miranda JJ, Shrestha L, Chandyo RK, Cattamanchi A, Michie S, Barber J, Checkley W, Hurst JR; GECo Study Investigators.

Trials. 2018 Oct 19;19(1):571. doi: 10.1186/s13063-018-2909-8.

3.

Reply to: Different Background, Short Duration, Inappropriate Participants May Harm Your Conclusion.

Chapman KR, Hurst JR, Fogel RB, Pfister P, Kostikas K, Wedzicha JA; SUNSET investigators.

Am J Respir Crit Care Med. 2018 Oct 18. doi: 10.1164/rccm.201809-1776LE. [Epub ahead of print] No abstract available.

PMID:
30335471
4.

Cardiovascular disease and COPD: dangerous liaisons?

Rabe KF, Hurst JR, Suissa S.

Eur Respir Rev. 2018 Oct 3;27(149). pii: 180057. doi: 10.1183/16000617.0057-2018. Print 2018 Sep 30. Review.

5.

Validation of the Saint George's Respiratory Questionnaire in Uganda.

Morgan BW, Grigsby MR, Siddharthan T, Kalyesubula R, Wise RA, Hurst JR, Kirenga B, Checkley W.

BMJ Open Respir Res. 2018 Jul 11;5(1):e000276. doi: 10.1136/bmjresp-2018-000276. eCollection 2018.

6.

The unmet global burden of COPD.

Quaderi SA, Hurst JR.

Glob Health Epidemiol Genom. 2018 Apr 6;3:e4. doi: 10.1017/gheg.2018.1. eCollection 2018. No abstract available.

7.

Consolidation and Exacerbation of COPD.

Hurst JR.

Med Sci (Basel). 2018 Jun 1;6(2). pii: E44. doi: 10.3390/medsci6020044. Review.

8.

Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.

Chapman KR, Hurst JR, Frent SM, Larbig M, Fogel R, Guerin T, Banerji D, Patalano F, Goyal P, Pfister P, Kostikas K, Wedzicha JA.

Am J Respir Crit Care Med. 2018 Aug 1;198(3):329-339. doi: 10.1164/rccm.201803-0405OC.

9.

Pollution and respiratory disease: can diet or supplements help? A review.

Whyand T, Hurst JR, Beckles M, Caplin ME.

Respir Res. 2018 May 2;19(1):79. doi: 10.1186/s12931-018-0785-0. Review.

10.

Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis.

Hurst JR, Dilleen M, Morris K, Hills S, Emir B, Jones R.

Int J Chron Obstruct Pulmon Dis. 2018 Mar 5;13:781-792. doi: 10.2147/COPD.S153655. eCollection 2018.

11.

Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Disease. A View from the SUMMIT.

Hurst JR, Sin DD.

Am J Respir Crit Care Med. 2018 Jul 1;198(1):2-4. doi: 10.1164/rccm.201802-0347ED. No abstract available.

PMID:
29533679
12.

Streptococcal pharyngitis and rheumatic heart disease: the superantigen hypothesis revisited.

Hurst JR, Kasper KJ, Sule AN, McCormick JK.

Infect Genet Evol. 2018 Jul;61:160-175. doi: 10.1016/j.meegid.2018.03.006. Epub 2018 Mar 9. Review.

PMID:
29530660
13.

COPD exacerbations: transforming outcomes through research.

Hurst JR, Bafadhel M, Bolton CE, Quint JK, Sapey E, Wilkinson TMA.

Lancet Respir Med. 2018 Mar;6(3):172-174. doi: 10.1016/S2213-2600(18)30049-3. Epub 2018 Feb 9. No abstract available.

14.

Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?

Wilson KC, Krishnan JA, Sliwinski P, Criner GJ, Miravitlles M, Hurst JR, Calverley PMA, Albert RK, Rigau D, Tonia T, Vestbo J, Papi A, Rabe KF, Anzueto A, Wedzicha JA.

Eur Respir J. 2018 Jan 11;51(1). pii: 1702577. doi: 10.1183/13993003.02577-2017. Print 2018 Jan. No abstract available.

PMID:
29326324
15.

Manifold Learning of COPD.

Bragman FJS, McClelland JR, Jacob J, Hurst JR, Hawkes DJ.

Med Image Comput Comput Assist Interv. 2017 Sep;10435:46-54. doi: 10.1007/978-3-319-66179-7_6. Epub 2017 Sep 4.

16.

Correlates and assessment of excess cardiovascular risk in bronchiectasis.

Saleh AD, Kwok B, Brown JS, Hurst JR.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701127. doi: 10.1183/13993003.01127-2017. Print 2017 Nov.

PMID:
29167299
17.

Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

Wedzicha JA, Calverley PMA, Albert RK, Anzueto A, Criner GJ, Hurst JR, Miravitlles M, Papi A, Rabe KF, Rigau D, Sliwinski P, Tonia T, Vestbo J, Wilson KC, Krishnan JA.

Eur Respir J. 2017 Sep 9;50(3). pii: 1602265. doi: 10.1183/13993003.02265-2016. Print 2017 Sep.

PMID:
28889106
18.

Effect of time and day of admission on hospital care quality for patients with chronic obstructive pulmonary disease exacerbation in England and Wales: single cohort study.

Roberts CM, Lowe D, Skipper E, Steiner MC, Jones R, Gelder C, Hurst JR, Lowrey GE, Thompson C, Stone RA.

BMJ Open. 2017 Sep 6;7(9):e015532. doi: 10.1136/bmjopen-2016-015532.

19.

Susceptibility to exacerbation in COPD.

Hurst JR, Anzueto A, Vestbo J.

Lancet Respir Med. 2017 Sep;5(9):e29. doi: 10.1016/S2213-2600(17)30307-7. No abstract available.

PMID:
28853400
20.

Prevalence and risk factors of restrictive spirometry in a cohort of Peruvian adults.

Siddharthan T, Grigsby M, Miele CH, Bernabe-Ortiz A, Miranda JJ, Gilman RH, Wise RA, Porter JC, Hurst JR, Checkley W.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1062-1068. doi: 10.5588/ijtld.17.0101.

PMID:
28826457
21.

One-off Spirometry Is Insufficient to Rule In or Rule Out Mild to Moderate Chronic Obstructive Pulmonary Disease.

Quaderi S, Hurst JR.

Am J Respir Crit Care Med. 2017 Aug 1;196(3):254-256. doi: 10.1164/rccm.201703-0551ED. No abstract available.

22.

Respiratory Infections and Antibiotic Usage in Common Variable Immunodeficiency.

Sperlich JM, Grimbacher B, Workman S, Haque T, Seneviratne SL, Burns SO, Reiser V, Vach W, Hurst JR, Lowe DM.

J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):159-168.e3. doi: 10.1016/j.jaip.2017.05.024. Epub 2017 Jul 19.

PMID:
28734862
23.

Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial.

Murphy PB, Rehal S, Arbane G, Bourke S, Calverley PMA, Crook AM, Dowson L, Duffy N, Gibson GJ, Hughes PD, Hurst JR, Lewis KE, Mukherjee R, Nickol A, Oscroft N, Patout M, Pepperell J, Smith I, Stradling JR, Wedzicha JA, Polkey MI, Elliott MW, Hart N.

JAMA. 2017 Jun 6;317(21):2177-2186. doi: 10.1001/jama.2017.4451.

24.

The heterogeneity of systemic inflammation in bronchiectasis.

Saleh AD, Chalmers JD, De Soyza A, Fardon TC, Koustas SO, Scott J, Simpson AJ, Brown JS, Hurst JR.

Respir Med. 2017 Jun;127:33-39. doi: 10.1016/j.rmed.2017.04.009. Epub 2017 Apr 17.

PMID:
28502416
25.

Pulmonary Lobe Segmentation With Probabilistic Segmentation of the Fissures and a Groupwise Fissure Prior.

Bragman FJS, McClelland JR, Jacob J, Hurst JR, Hawkes DJ.

IEEE Trans Med Imaging. 2017 Aug;36(8):1650-1663. doi: 10.1109/TMI.2017.2688377. Epub 2017 Apr 18.

26.

British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.

Hurst JR, Verma N, Lowe D, Baxendale HE, Jolles S, Kelleher P, Longhurst HJ, Patel SY, Renzoni EA, Sander CR, Avery GR, Babar JL, Buckland MS, Burns S, Egner W, Gompels MM, Gordins P, Haddock JA, Hart SP, Hayman GR, Herriot R, Hoyles RK, Huissoon AP, Jacob J, Nicholson AG, Rassl DM, Sargur RB, Savic S, Seneviratne SL, Sheaff M, Vaitla PM, Walters GI, Whitehouse JL, Wright PA, Condliffe AM.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):938-945. doi: 10.1016/j.jaip.2017.01.021. Epub 2017 Mar 25. Review.

27.

Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

Wedzicha JA Ers Co-Chair, Miravitlles M, Hurst JR, Calverley PM, Albert RK, Anzueto A, Criner GJ, Papi A, Rabe KF, Rigau D, Sliwinski P, Tonia T, Vestbo J, Wilson KC, Krishnan JA Ats Co-Chair.

Eur Respir J. 2017 Mar 15;49(3). pii: 1600791. doi: 10.1183/13993003.00791-2016. Print 2017 Mar.

28.

How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?

Beeh KM, Burgel PR, Franssen FME, Lopez-Campos JL, Loukides S, Hurst JR, Fležar M, Ulrik CS, Di Marco F, Stolz D, Valipour A, Casserly B, Ställberg B, Kostikas K, Wedzicha JA.

Am J Respir Crit Care Med. 2017 Jul 15;196(2):139-149. doi: 10.1164/rccm.201609-1794CI. Review.

29.

Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records.

Rothnie KJ, Müllerová H, Thomas SL, Chandan JS, Smeeth L, Hurst JR, Davis K, Quint JK.

Clin Epidemiol. 2016 Nov 21;8:771-782. eCollection 2016.

31.

Dyspnoea perception and susceptibility to exacerbation in COPD.

Ridsdale HA, Hurst JR.

Thorax. 2017 Feb;72(2):107-108. doi: 10.1136/thoraxjnl-2016-209318. Epub 2016 Nov 4. No abstract available.

PMID:
27815522
32.

Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.

Geerdink JX, Simons SO, Pike R, Stauss HJ, Heijdra YF, Hurst JR.

Respir Res. 2016 Oct 28;17(1):140.

33.

Bronchiectasis and the risk of cardiovascular disease: a population-based study.

Navaratnam V, Millett ER, Hurst JR, Thomas SL, Smeeth L, Hubbard RB, Brown J, Quint JK.

Thorax. 2017 Feb;72(2):161-166. doi: 10.1136/thoraxjnl-2015-208188. Epub 2016 Aug 29.

34.

Update on alpha-1 antitrypsin deficiency: New therapies.

Lomas DA, Hurst JR, Gooptu B.

J Hepatol. 2016 Aug;65(2):413-24. doi: 10.1016/j.jhep.2016.03.010. Epub 2016 Mar 29. Review.

PMID:
27034252
35.

Precision Medicine in Chronic Obstructive Pulmonary Disease.

Hurst JR.

Am J Respir Crit Care Med. 2016 Mar 15;193(6):593-4. doi: 10.1164/rccm.201601-0104ED. No abstract available.

PMID:
26977962
36.

Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records.

Rothnie KJ, Müllerová H, Hurst JR, Smeeth L, Davis K, Thomas SL, Quint JK.

PLoS One. 2016 Mar 9;11(3):e0151357. doi: 10.1371/journal.pone.0151357. eCollection 2016.

37.

Lung consequences in adults born prematurely.

Bolton CE, Bush A, Hurst JR, Kotecha S, McGarvey L.

Postgrad Med J. 2015 Dec;91(1082):712-8. doi: 10.1136/postgradmedj-2014-206590rep. Review.

PMID:
26607737
38.

Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study.

Quint JK, Millett ER, Joshi M, Navaratnam V, Thomas SL, Hurst JR, Smeeth L, Brown JS.

Eur Respir J. 2016 Jan;47(1):186-93. doi: 10.1183/13993003.01033-2015. Epub 2015 Nov 5.

39.

Letters to the editor.

Buss L, Hurst JR.

Clin Med (Lond). 2015 Oct;15(5):499. doi: 10.7861/clinmedicine.15-5-499. No abstract available.

PMID:
26430197
40.

Role of a functional polymorphism in the F2R gene promoter in sarcoidosis.

Platé M, Lawson PJ, Hill MR, Marshall RP, Booth HL, Kumari M, Laurent GJ, Hurst JR, Chambers RC.

Respirology. 2015 Nov;20(8):1285-7. doi: 10.1111/resp.12608. Epub 2015 Aug 17.

41.

Lung disease in primary antibody deficiency.

Verma N, Grimbacher B, Hurst JR.

Lancet Respir Med. 2015 Aug;3(8):651-60. doi: 10.1016/S2213-2600(15)00202-7. Epub 2015 Jul 15. Review.

PMID:
26188881
42.

Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial.

Brill SE, Law M, El-Emir E, Allinson JP, James P, Maddox V, Donaldson GC, McHugh TD, Cookson WO, Moffatt MF, Nazareth I, Hurst JR, Calverley PM, Sweeting MJ, Wedzicha JA.

Thorax. 2015 Oct;70(10):930-8. doi: 10.1136/thoraxjnl-2015-207194. Epub 2015 Jul 15.

43.

Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease.

Benson VS, Müllerová H, Vestbo J, Wedzicha JA, Patel A, Hurst JR; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators.

Respir Med. 2015 Sep;109(9):1147-54. doi: 10.1016/j.rmed.2015.06.009. Epub 2015 Jun 23.

44.

Deficiency Mutations of Alpha-1 Antitrypsin. Effects on Folding, Function, and Polymerization.

Haq I, Irving JA, Saleh AD, Dron L, Regan-Mochrie GL, Motamedi-Shad N, Hurst JR, Gooptu B, Lomas DA.

Am J Respir Cell Mol Biol. 2016 Jan;54(1):71-80. doi: 10.1165/rcmb.2015-0154OC.

45.

The use of whole-exome sequencing to disentangle complex phenotypes.

Williams HJ, Hurst JR, Ocaka L, James C, Pao C, Chanudet E, Lescai F, Stanescu HC, Kleta R; GOSgene, Rosser E, Bacchelli C, Beales P.

Eur J Hum Genet. 2016 Feb;24(2):298-301. doi: 10.1038/ejhg.2015.121. Epub 2015 Jun 10.

46.

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Eur Respir Rev. 2015 Jun;24(136):159-72. doi: 10.1183/16000617.00000315. Review.

47.

Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study.

Brill SE, Patel AR, Singh R, Mackay AJ, Brown JS, Hurst JR.

Respir Res. 2015 Feb 7;16:16. doi: 10.1186/s12931-015-0167-9.

48.

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27. doi: 10.1164/rccm.201501-0044ST.

PMID:
25830527
49.

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Eur Respir J. 2015 Apr;45(4):879-905. doi: 10.1183/09031936.00009015. Review.

50.

Lung consequences in adults born prematurely.

Bolton CE, Bush A, Hurst JR, Kotecha S, McGarvey L.

Thorax. 2015 Jun;70(6):574-80. doi: 10.1136/thoraxjnl-2014-206590. Epub 2015 Mar 30. Review.

Supplemental Content

Loading ...
Support Center